Please remember that CRL tend to come with an approval, once concerns are answered. Which has been shown by another poster. I think we all suspected this as an outcome. But please remember FDA has NOT rejected. Type A means 2-3 months. And Mesoblast will urgently request a
Type A meeting with the FDA, expected within 30 days, to discuss a potential accelerated approval with a
post-approval condition for an additional study.
Hang on the ride is going to be steep today.
Ann: Update on BLA for Graft Versus Host Disease, page-120
-
- There are more pages in this discussion • 436 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.00 |
Change
-0.023(2.20%) |
Mkt cap ! $1.164B | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.04 | $1.00 | $2.609M | 2.551M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 543654 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 34188 | 8 |
View Market Depth
| Last trade - 11.35am 24/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |